Effects of intravenous glucose and lipids on innate immune cell activation in healthy, obese, and type 2 diabetic subjects

Physiological Reports

Volumn 3, Issue 2, 2015, Pages

  Horvath, Peter ^a   Oliver, Stacy R ^b   Zaldivar, Frank P ^a   Radom Aizik, Shlomit ^a   Galassetti, Pietro R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Glucose; Granulocytes; Lipids; Monocytes

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CHEMOKINE RECEPTOR CCR2; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; L SELECTIN; LIPID;

ADULT; ARTICLE; BLOOD CELL COUNT; BODY MASS; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; GRANULOCYTE; HUMAN; INNATE IMMUNITY; MALE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL BLOOD MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84973370597     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12249     Document Type: Article

References (64)

1. Amend, K. L., J. Landon, V. Thyagarajan, S. Niemcryk, and A. McAfee. 2011. Incidence of hospitalized rhabdomyolysis with statin and fibrate use in an insured US population. Ann. Pharmacother. 45:1230–1239.
2. Barma, P., S. Bhattacharya, A. Bhattacharya, R. Kundu, S. Dasgupta, A. Biswas, et al. 2009. Lipid induced overexpression of NF-kappaB in skeletal muscle cells is linked to insulin resistance. Biochim. Biophys. Acta 3:190–200.
3. Boschmann, M., S. Engeli, F. Adams, K. Gorzelniak, G. Franke, S. Klaua, et al. 2005. Adipose tissue metabolism and CD11b expression on monocytes in obese hypertensives. Hypertension 46:130–136.
4. Cavalot, F., A. Petrelli, M. Traversa, K. Bonomo, E. Fiora, M. Conti, et al. 2006. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J. Clin. Endocrinol. Metab. 91:813–819.
5. Ceriello, A. 1998. The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications. Diabet. Med. 15:188–193.
6. Cottam, D. R., P. A. Schaefer, D. Fahmy, G. W. Shaftan, and L. D. Angus. 2002. The effect of obesity on neutrophil Fc receptors and adhesion molecules (CD16, CD11b, CD62L). Obes. Surg. 12:230–235.
7. Dart, A. M., and J. P. Chin-Dusting. 1999. Lipids and the endothelium. Cardiovasc. Res. 43:308–322.
8. Di Prospero, N. A., E. Artis, P. Andrade-Gordon, D. L. Johnson, N. Vaccaro, L. Xi, et al. 2014. CCR2 antagonism in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study. Diabetes Obese. Metabol. 11:1055–1064.
9. Domagala, B. M., M. Leady, and D. S. Streetman. 2003. Ezitimibe: the first cholesterol absorption inhibitor. Pharm. Spotlight 28:191–206.
10. Drechsler, M., R. T. Megens, Z. M. van, C. Weber, and O. Soehnlein. 2010. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 122:1837–1845.
11. El-Raggal, N., M. El-Barbary, M. Youssef, and H. El-Mans. 2004. Neutrophil-surface antigens CD11b and CD64 expression: a potential predictor of early-onset neonatal sepsis. Egypt J. Pediatr. Allergy Immunol. 2:90–100.
12. Emanuela, F., M. Grazia, D. R. Marco, P. L. Maria, F. Giorgio, and B. Marco. 2012. Inflammation as a Link between Obesity and Metabolic Syndrome. J. Nutr. Metab. 2012:476380.
13. Esposito, K., F. Nappo, R. Marfella, G. Giugliano, F. Giugliano, M. Ciotola, et al. 2002. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106:2067–2072.
14. Esposito, K., F. Nappo, F. Giugliano, P. C. Di, M. Ciotola, M. Barbieri, et al. 2003. Cytokine milieu tends toward inflammation in type 2 diabetes. Diabetes Care 26:1647.
15. Fain, J. N. 2006. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam. Horm. 74:443–477.
16. Franceschi, C., and J. Campisi. 2014. Chronic inflammation (inflammaging) and its potential contribution to ageassociated diseases. J. Gerontol. A Biol. Sci. Med. Sci. 69:S4–S9.
17. Glynn, P., R. Coakley, I. Kilgallen, and S. O’Neill. 1999. Neutrophil CD11b and soluble ICAM-1 and E-selectin in community acquired pneumonia. Eur. Respir. J. 6:1380–1385.
18. Groot, P.H., W. A. van Stiphout, X. H. Krauss, H. Jansen, T. A. van, R. E. van, et al. 1991. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler. Thromb. 11:653–662.
19. Han, K. H., K. O. Han, S. R. Green, and O. Quehenberger. 1999. Expression of the monocyte chemoattractant protein-1 receptor CCR2 is increased in hypercholesterolemia. Differential effects of plasma lipoproteins on monocyte function. J. Lipid Res. 40:1053–1063.
20. Harsimran, K., A. A. Singh, S. Guruvinder, S. Sharda, and S. Vasudha. 2009. Plasma monocyte chemoattractant protein-1 as risk marker in type 2 diabetes mellitus and coronary artery disease in North Indians. Diab. Vasc. Dis. Res. 6:288–290.
21. Herder, C., E. J. Brunner, W. Rathmann, K. Strassburger, A. G. Tabak, N. C. Schloot, et al. 2009. Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II study. Diabetes Care 32:421–423.
22. Herieka, M., and C. Erridge. 2014. High-fat meal induced postprandial inflammation. Mol. Nutr. Food Res. 58:136–146.
23. Hoffmann, E., O. Ttrich-Breiholz, H. Holtmann, and M. Kracht. 2002. Multiple control of interleukin-8 gene expression. J. Leukoc. Biol. 72:847–855.
24. Ionita, M. G., B. P. van den, L. M. Catanzariti, F. L. Moll, J. P. de Vries, G. Pasterkamp, et al. 2010. High neutrophil numbers in human carotid atherosclerotic plaques are associated with characteristics of rupture-prone lesions. Arterioscler. Thromb. Vasc. Biol. 30:1842–1848.
25. Jain, M., F. W. LoGerfo, P. Guthrie, and L. Pradhan. 2011. Effect of hyperglycemia and neuropeptides on interleukin-8 expression and angiogenesis in dermal microvascular endothelial cells. J. Vasc. Surg. 53:1654–1660.
26. Juge-Aubry, C. E., E. Somm, V. Giusti, A. Pernin, R. Chicheportiche, C. Verdumo, et al. 2003. Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation. Diabetes 52:1104–1110.
27. Kassirer, M., D. Zeltser, V. Prochorov, G. Schoenman, A. Frimerman, G. Keren, et al. 1999. Increased expression of the CD11b/CD18 antigen on the surface of peripheral white blood cells in patients with ischemic heart disease: further evidence for smoldering inflammation in patients with atherosclerosis. Am. Heart J. 138:555–559.
28. Kim, C. S., H. S. Park, T. Kawada, J. H. Kim, D. Lim, N. E. Hubbard, et al. 2006. Circulating levels of MCP-1 and IL- 8 are elevated in human obese subjects and associated with obesity-related parameters. Int. J. Obes. (Lond) 30:1347–1355.
29. Kleinbongard, P., G. Heusch, and R. Schulz. 2010. TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol. Ther. 127:295–314.
30. Klop, B., S. D. Proctor, J. C. Mamo, K. M. Botham, and C. M. Castro. 2012. Understanding postprandial inflammation and its relationship to lifestyle behaviour and metabolic diseases. Int. J. Vasc. Med. 2012:947417.
31. Libby, P. 2002. Inflammation in atherosclerosis. Nature 420:868–874.
32. Luppi, P., V. Cifarelli, H. Tse, J. Piganelli, and M. Trucco. 2008. Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-kappaB pathway. Diabetologia 51:1534–1543.
33. Magne, J., F. Mariotti, R. Fischer, V. Mathe, D. Tome, and J. F. Huneau. 2010. Early postprandial low-grade inflammation after high-fat meal in healthy rats: possible involvement of visceral adipose tissue. J. Nutr. Biochem. 21:550–555.
34. Marcus, F. I., A. J. Baumgarten, W. L. Fritz, and P. E. Jr Nolan. 2013. Alternate-day dosing with statins. Am. J. Med. 126:99–104.
35. Mastej, K., and R. Adamiec. 2009. Neutrophil surface expression of adhesion molecule CD11b in patients with type 2 diabetes. Przegl. Lek. 66:228–232.
36. Meier, C. A., E. Bobbioni, C. Gabay, F. Assimacopoulos- Jeannet, A. Golay, and J. M. Dayer. 2002. IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin? J. Clin. Endocrinol. Metab. 87:1184–1188.
37. Mirza, S., M. Hossain, C. Mathews, P. Martinez, P. Pino, J. L. Gay, et al. 2012. Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study. Cytokine 57:136–142.
38. Mochizuki, K., M. Shimada, Y. Tanaka, N. Fukaya, and T. Goda. 2010. Reduced expression of beta2 integrin genes in rat peripheral leukocytes by inhibiting postprandial hyperglycemia. Biosci. Biotechnol. Biochem. 74:2470–2474.
39. Noble, J. M., G. A. Ford, and T. H. Thomas. 1999. The effect of aging on CD11b and CD69 surface expression by vesicular insertion in human polymorphonuclear leucocytes. Clin. Sci. (Lond.) 3:323–329.
40. Nowotny, B., L. Zahiragic, D. Krog, P. J. Nowotny, C. Herder, M. Carstensen, et al. 2013. Mechanisms underlying the onset of oral lipid-induced skeletal muscle insulin resistance in humans. Diabetes 62:2240–2248.
41. Ohman, M. K., A. P. Wright, K. J. Wickenheiser, W. Luo, H. M. Russo, and D. T. Eitzman. 2010. Monocyte chemoattractant protein-1 deficiency protects against visceral fat-induced atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 30:1151–1158.
42. Okamoto, M., M. Fuchigami, T. Suzuki, and N. Watanabe. 2012. A novel C-C chemokine receptor 2 antagonist prevents progression of albuminuria and atherosclerosis in mouse models. Biol. Pharm. Bull. 35:2069–2074.
43. van Oostrom, A. J., T. J. Rabelink, C. Verseyden, T. P. Sijmonsma, H. W. Plokker, P. P. De Jaegere, et al. 2004a. Activation of leukocytes by postprandial lipemia in healthy volunteers. Atherosclerosis 177:175–182.
44. van Oostrom, A. J., J. P. van Wijk, T. P. Sijmonsma, T. J. Rabelink, and C. M. Castro. 2004b. Increased expression of activation markers on monocytes and neutrophils in type 2 diabetes. Neth. J. Med. 62:320–325.
45. Packard, R. R., and P. Libby. 2008. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin. Chem. 54:24–38.
46. Pahan, K. 2006. Lipid-lowering drugs. Cell. Mol. Life Sci. 63:1165–1178.
47. Patel, S., and D. Santani. 2009. Role of NF-kappaB in the pathogenesis of diabetes and its associated complications. Pharmacol. Rep. 4:595–603.
48. Patino, R., J. Ibarra, A. Rodriguez, M. R. Yague, E. Pintor, A. Fernandez-Cruz, et al. 2000. Circulating monocytes in patients with diabetes mellitus, arterial disease, and increased CD14 expression. Am. J. Cardiol. 85:1288–1291.
49. Quan, Y., C. T. Jiang, B. Xue, S. G. Zhu, and X. Wang. 2011. High glucose stimulates TNFalpha and MCP-1 expression in rat microglia via ROS and NF-kappaB pathways. Acta Pharmacol. Sin. 32:188–193.
50. Razmara, M., P. Hjemdahl, M. Yngen, C. G. Ostenson, N. H. Wallen, and N. Li. 2007. Food intake enhances thromboxane receptor-mediated platelet activation in type 2 diabetic patients but not in healthy subjects. Diabetes Care 30:138–140.
51. Roytblat, L., M. Rachinsky, A. Fisher, L. Greemberg, Y. Shapira, A. Douvdevani, et al. 2000. Raised interleukin-6 levels in obese patients. Obes. Res. 8:673–675.
52. Ruan, H., H. J. Pownall, and H. F. Lodish. 2003. Troglitazone antagonizes tumor necrosis factor-alpha-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NFkappaB. J. Biol. Chem. 30:28181–28192.
53. Sampson, M. J., I. R. Davies, J. C. Brown, K. Ivory, and D. A. Hughes. 2002. Monocyte and neutrophil adhesion molecule expression during acute hyperglycemia and after antioxidant treatment in type 2 diabetes and control patients. Arterioscler. Thromb. Vasc. Biol. 22:1187–1193.
54. Sartipy, P., and D. J. Loskutoff. 2003. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl Acad. Sci. USA 100:7265–7270.
55. Shin, J. Y., S. Y. Kim, M. J. Jeung, S. H. Eun, C. W. Woo, S. Y. Yoon, et al. 2008. Serum adiponectin, C-reactive protein and TNF-alpha levels in obese Korean children. J. Pediatr. Endocrinol. Metab. 21:23–29.
56. Stoneman, V., D. Braganza, N. Figg, J. Mercer, R. Lang, M. Goddard, et al. 2007. Monocyte/macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques. Circ. Res. 100:884–893.
57. Strieter, R. M., R. Wiggins, S. H. Phan, B. L. Wharram, H. J. Showell, D. G. Remick, et al. 1989. Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells. Biochem. Biophys. Res. Commun. 162:694–700.
58. Sullivan, T. J., Z. Miao, B. N. Zhao, L. S. Ertl, Y. Wang, A. Krasinski, et al. 2013. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes. Metabolism 62:1623–1632.
59. Takaishi, H., T. Taniguchi, A. Takahashi, Y. Ishikawa, and M. Yokoyama. 2003. High glucose accelerates MCP-1 production via p38 MAPK in vascular endothelial cells. Biochem. Biophys. Res. Commun. 305:122–128.
60. Tedder, T. F., D. A. Steeber, and P. Pizcueta. 1995. L-selectindeficient mice have impaired leukocyte recruitment into inflammatory sites. J. Exp. Med. 181:2259–2
61. von der Thusen, J. H., J. Kuiper, T. J. van Berkel, and E. A. Biessen. 2003. Interleukins in atherosclerosis: molecular pathways and therapeutic potential. Pharmacol. Rev. 55:133–166.
62. Wanten, G. J., T. B. Geijtenbeek, R. A. Raymakers, K. Y. van, D. Roos, J. B. Jansen, et al. 2000. Medium-chain, triglyceride-containing lipid emulsions increase human neutrophil beta2 integrin expression, adhesion, and degranulation. J. Parenter. Enteral. Nutr. 24:228–233.
63. Weber, C., and H. Noels. 2011. Atherosclerosis: current pathogenesis and therapeutic options. Nat. Med. 17:1410–1422.
64. Zini, E., M. Osto, D. Konrad, M. Franchini, N. S. Sieber-Ruckstuhl, K. Kaufmann, et al. 2010. 10-day hyperlipidemic clamp in cats: effects on insulin sensitivity, inflammation, and glucose metabolism-related genes. Horm. Metab. Res. 42:340–347.